MEMPHIS, Tenn.--(EON: Enhanced Online News)--TriMetis Life Sciences, a preclinical services company dedicated to helping companies accelerate their research through access to specialized in-vivo and in-vitro laboratories, quality human biospecimen acquisition and Non-GLP/GLP research expertise, is expanding into the biotech hub of Kendall Square in Cambridge, Mass.
The new office is located in the Cambridge Innovation Center (CIC), which is home to more than 900 companies.
“Centralizing our Boston office in an entrepreneurial community like CIC provides the TriMetis team and our customers greater access to each other. Conducting the right testing at the right time is a critical component of product development for pharmaceutical, biotech, diagnostic and medical device companies of all sizes and stages. We believe this increased exposure is essential to providing the preclinical testing and consulting services that our customers need,” said Phil Cestaro, TriMetis CEO.
CIC will allow TriMetis to increase its preclinical support in the Boston innovation industry. While at CIC, TriMetis will continue to mentor start-ups, by hosting educational events, informational meetings, and networking opportunities. For more information, please contact Mariel Maling at email@example.com or visit our website at trimetislifesciences.com.
While at CIC, TriMetis will continue to mentor start-ups, by hosting educational events, informational meetings, and networking opportunities.
TriMetis owns and operates a 26,000-square-foot GLP, AAALAC-Accredited research facility located on the UT-Baptist Research Park in Memphis, Tenn.